Six-transmembrane epithelial antigen of the prostate as an immunotherapeutic target for renal cell and bladder cancer.
Azumi
Makoto
M
Department of Urology, Asahikawa Medical College, Asahikawa, Japan. mazumi@asahikawa-med.ac.jp
Kobayashi
Hiroya
H
Aoki
Naoko
N
Sato
Keisuke
K
Kimura
Shoji
S
Kakizaki
Hidehiro
H
Tateno
Masatoshi
M
D017951:Antigen Presentation; D000951:Antigens, Neoplasm / Q000276:immunology*; D045744:Cell Line, Tumor; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology; D006801:Humans; D007124:Immunoenzyme Techniques; D007167:Immunotherapy / Q000379:methods*; D007680:Kidney Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D010088:Oxidoreductases / Q000276:immunology*; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology*; D014162:Transfection; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*
D000951:Antigens, Neoplasm; D018984:Epitopes, T-Lymphocyte; D006684:HLA-DR Antigens; D010088:Oxidoreductases; C432763:STEAP1 protein, human